Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN319272 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-V-Akt Murine Thymoma Viral Oncogene Homolog 1 (AKT1) (pThr450) antibody
- Antibody type
- Polyclonal
- Description
- Immunoaffinity Chromatography: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- pThr450
- Vial size
- 50 μL
- Storage
- Store the antibody (in aliquots) at-20°C.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.
Mitochondria, aging and longevity--a new perspective.
BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.
New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.
It's prime time for reverse transcriptase.
Sarbassov DD, Guertin DA, Ali SM, Sabatini DM
Science (New York, N.Y.) 2005 Feb 18;307(5712):1098-101
Science (New York, N.Y.) 2005 Feb 18;307(5712):1098-101
Mitochondria, aging and longevity--a new perspective.
Salvioli S, Bonafè M, Capri M, Monti D, Franceschi C
FEBS letters 2001 Mar 9;492(1-2):9-13
FEBS letters 2001 Mar 9;492(1-2):9-13
BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.
Gesbert F, Sellers WR, Signoretti S, Loda M, Griffin JD
The Journal of biological chemistry 2000 Dec 15;275(50):39223-30
The Journal of biological chemistry 2000 Dec 15;275(50):39223-30
New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.
Cantley LC, Neel BG
Proceedings of the National Academy of Sciences of the United States of America 1999 Apr 13;96(8):4240-5
Proceedings of the National Academy of Sciences of the United States of America 1999 Apr 13;96(8):4240-5
It's prime time for reverse transcriptase.
Levin HL
Cell 1997 Jan 10;88(1):5-8
Cell 1997 Jan 10;88(1):5-8
No comments: Submit comment
No validations: Submit validation data